期刊文献+

瘦素、脂蛋白α在食管鳞状细胞癌中的表达及其临床意义 被引量:1

Expressions of leptin and lipoprotein α in esophageal squamous cell carcinoma and their clinical significance
原文传递
导出
摘要 目的探讨食管鳞状细胞癌(食管鳞癌)患者血清瘦素、血脂水平以及临床意义,为食管鳞癌的防治提供科学依据。方法收集术前未经任何治疗的食管鳞癌患者47例,健康对照组20名,采用酶联免疫吸附法(ELISA)测定血清瘦素水平,全自动生化分析α测定血脂水平,采用SPSS17.0软件对数据进行t检验、相关性分析、Logistic分析等统计学处理。结果食管鳞癌患者及健康对照血清瘦素水平分别为(13.09±5.94)ng/ml、(7.58±4.16)ng/ml,差异有统计学意义(t=3.76,P=0.001);脂质蛋白仅(LPd)水平分别为(216.50±152.53)mg/L和(87.85±10.73)mg/L,差异有统计学意义(t=3.751,P=0.001),而食管鳞癌患者三酰甘油(TG)水平[(1.23±0.46)mmol/L]明显低于对照组[(1.58±0.07)mmo]/L],差异有统计学意义(t=-3.342,P=0.001)。Logistic回归分析结果显示,瘦素水平的增高,增加了食管鳞癌的发生风险(ORleptin=1.442,P=0.009),而TG、LPa水平的改变并不影响食管鳞癌的发生风险。结论血清瘦素水平的升高可能增加食管鳞癌的发生风险,LPα水平的升高可能是机体的一个代偿反应。 Objective to investigate serum leptin concentration and lipdid levels in patients with esophageal squamous cell carcinoma and their clinical significance. Methods Blood samples were collected from 47 patients with esophageal cancer, 20 healthy control subjects. Serum leptin was measured by ELISA and serum lipids was measured by biochemistry auto-analyzer. Results The serum leptin concentration and LP αlevels in patients group were significantly higher than those in control group[(13.09±5.94) ng/ml vs (7.584± 4.15) ng/ml,(216.50±752.52) ng/ml vs(87.85±10.73) mg/L](P=0.001). However, the TG concentration was significantly lower than control group [(1.23±0.46) mmol/L vs (1.58±0.07) mmol/L] (P=0.001). Multiple logistic regression analysis revealed statistically significant association between serum leptin levels and esophageal squamous cell carcinoma incident (ORleptin =1.442,95% CI 1.094-1.848). Conclusion The increased serum leptin levels maybe the risk factors of esophageal cancer, elevated LP α levels in patients might be a compensatory reactions.
出处 《肿瘤研究与临床》 CAS 2012年第7期440-443,共4页 Cancer Research and Clinic
关键词 食管肿瘤 鳞状细胞 血脂 瘦素 Esophageal neoplasms Carcinoma, spuamous cell Lipids Leptin
  • 相关文献

参考文献44

  • 1Zhang Y,Maffei M,Barone M,et al. Positional cloning of the mouseobese gene and its human homologue. Nature, 1994,372:425- 432.
  • 2Chu N F,Spiegelman D, Hotamisligil G S,et al. Plasma Insulin, leptin, and soluble TNF receptors levels in relation to obesity- relatedatherogenie and thrombogenic cardiovascul,disease risk factors among men. Atherosdemsis, 2001,157 : 495-503.
  • 3Gary W. Falk, Risk Factors for esophageal adenocarcinoma. Surg Oncol Chn North Am,2009,18: 469-485.
  • 4Enzinger P C, Mayer R J. Esophageal cancer.N Engl J Med, 2003 349,2241-2252.
  • 5Abner CC, Freedman ND, Hollenbeck AR, et al. A prospective study of BMI andrisk of oesophageal and gastric adenocarcinoma. Eur J Cancer, 2008;44:465-471.
  • 6Merry AH, Schouten LJ, Goldbohm RA, et al. Body mass index, height and riskof adenocarcinoma of the oesophagus and gastric cardia: a prospective cohortstudy. Gut, 2007, 56:1503-1511.
  • 7Engeland A, Tretli S, Bj d~ rge T. Height and body mass index in relation to esophagealcancer; 23-year follow-up of two million Norwegian men and women.Cancer Causes Control, 2004, 15:837- 843.
  • 8Veugelers PJ, Porter GA, Guernsey DL, et al. Obesity and lifestyle risk factors forgastroesopbageal reflux disease, Barrett esophagus and esophageal adenocarcinoma.Dis Esophagus, 2006, 19:321-328.
  • 9Lagergren J, Bergstr~m R, Nyr6en O. Association between body mass of the esophagus and gastric cardia. Ann Intern Med, 1999, 130:883-890.
  • 10Chow WH, Blot WJ, Vaughan TL, et al. Body mass index and risk of adenocarcinomasof the esophagus and gastric cardla. J Natl Cancer Inst, 1998, 90:150-155.

二级参考文献33

  • 1高进霞,谭元菊.74例恶性血液疾病血脂分析[J].临床血液学杂志,1994,7(3):112-114. 被引量:6
  • 2武阳丰,马冠生,胡永华,李艳平,李贤,崔朝辉,陈春明,孔灵芝.中国居民的超重和肥胖流行现状[J].中华预防医学杂志,2005,39(5):316-320. 被引量:568
  • 3曾峰,肖伟民.不同癌症患者血清胆固醇水平的变化[J].中国误诊学杂志,2006,6(1):19-21. 被引量:12
  • 4杜丽莉,韩存芝,刘秀英,荆洁线,赵先文,田保国,谢燕红.血清瘦素水平及体质指数与乳腺癌发生的相关性研究[J].肿瘤研究与临床,2006,18(5):307-309. 被引量:8
  • 5侯振江,王秀文,张丽华,周秀艳,戴殿禄,闫金辉.肝细胞癌患者血清瘦素表达及其临床意义[J].中国现代医药杂志,2007,9(5):5-8. 被引量:5
  • 6Dessi S,Batetta B,Pulisci D,et al.Cholesterol content in tumor tissues is inversely associated with high density lipoprotein cholesterol in serum in patients with gastrointestinal cancer[J].Cancer,1994,73 (2):253-258.
  • 7Oram J F,Johnson C J,Brown T A.Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages[J].J Biol Chem,1987,262(5):2405-2410.
  • 8Guo E Q,Chen L R,Xie Q P,et al.Serum HDL-C as a Potential Biomarker for Nodal Stages in Gastric Cancer[J].Ann Surg Oncol,2007,14(9):2528-2534.
  • 9Shen L,Zhu X,Wang Y,et al.Secreted human apolipoprotein(a) kringle IV-10 and kringle V inhibit angiogenesis and xenografted tumor growth[J].Biol Chem,2008,389(2):135-141.
  • 10Yi Z F,Cho S G,Zhao H,et al.A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells[J].Int J Cancer,2009,124(4):843-852.

共引文献34

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部